Bone marrow transplantation assists in acceptance of donated organs

April 3, 2012

In an organ transplant the recipient protects himself with an immune reaction against the alien organ. This reaction is counteracted long-term with the use of immunosuppressants. In future this medication might no longer be necessary. If bone marrow belonging to the donor is also transplanted, no immune reaction occurs. However, this is still associated with undesirable side effects.

Thomas Wekerle from the University Department of Surgery, who on 1st April took up his position as the first Professor for Transplantation Immunology at the MedUni Vienna, is carrying out research on bone marrow models in order to eliminate these side effects.

The recipients concerned would of course have to be subjected to radiation beforehand and take cytostatics, synthetic substances that suppress cell growth or division. A treatment that is associated with hair falling out, nausea as well as a reduction in the white and/or in the blood.

"If this toxicity could be eliminated, it would be revolutionary," says Wekerle. The latest research results give rise to the hope that this revolution is not too far away. Wekerle: "There are major advances in this direction due to the use of from the recipient. These are so-called , a subtype of the already known T cells."

Double bone marrow suppresses the immune defence

The additional transplantation of bone marrow is known as "chimerism." The term comes from the chimera in Greek mythology, which was a hybrid creature. In case of chimerism, the patients have two bone marrows – their own and that of the donor. Says Wekerle: "If the donor bone marrow successfully takes, the recipient does not identify the donor organ as alien. Consequently, there is no . The patient’s body tolerates it." Initial pilot studies with kidney transplants have shown that this method is very promising.

Explore further: New transplant method may allow kidney recipients to live life free of anti-rejection medication

Related Stories

New transplant method may allow kidney recipients to live life free of anti-rejection medication

March 7, 2012
New ongoing research published today in the journal Science Translational Medicine suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may ...

Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient

December 12, 2011
Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, ...

Recommended for you

World's first child hand transplant a 'success'

July 19, 2017
The first child in the world to undergo a double hand transplant is now able to write, feed and dress himself, doctors said Tuesday, declaring the ground-breaking operation a success after 18 months.

Knee surgery—have we been doing it wrong?

July 18, 2017
A team of University at Buffalo medical doctors have published a study that challenges a surgical practice used for decades during arthroscopic knee surgery.

New tools help surgeons find liver tumors, not nick blood vessels

July 17, 2017
The liver is a particularly squishy, slippery organ, prone to shifting both deadly tumors and life-preserving blood vessels by inches between the time they're discovered on a CT scan and when the patient is lying on an operating ...

Researchers discover indicator of lung transplant rejection

July 13, 2017
Research by scientists at Dignity Health St. Joseph's Hospital and Medical Center's Norton Thoracic Institute was published in the July 12, 2017 issue of Science Translational Medicine titled "Zbtb7a induction in alveolar ...

New device could make closing surgical incisions a cinch

July 7, 2017
Like many surgeons, Dr. Jason Spector is often faced with the challenge of securely closing the abdominal wall without injuring the intestines. If the process goes awry, there can be serious consequences for patients, including ...

Success with first 20 patients undergoing minimally invasive pancreatic transplant surgery

June 29, 2017
Surgeons at Johns Hopkins Medicine report that their first series of a minimally invasive procedure to treat chronic pancreas disease, known as severe pancreatitis, resulted in shorter hospital stays, less need for opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.